Evidence map›Paper›PMID 10712507›Full record

ArticleMolecular biology of the cell2000

Activation of Wee1 by p42 MAPK in vitro and in cycling xenopus egg extracts.

S A Walter, S N Guadagno, J E Ferrell

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Control of oocyte growth and meiotic maturation in Caenorhabditis elegans.Advances in experimental medicine and biology · 2013
    Review
  7. Current and future trials of targeted therapies in cutaneous melanoma.Advances in experimental medicine and biology · 2013
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Control of Emi2 activity and stability through Mos-mediated recruitment of PP2A.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

S A WalterDepartment of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305-5332, USA.
S N Guadagno
J E Ferrell
Stanford University · USZoneOne Pharma (United States) · US

Funding

THE ROLE OF MAP KINASE IN THE CELL CYCLER01GM046383 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI FERRELL, JAMES E. · 1991 to 2018
$7.3M
NIGMS NIH HHS GM-46383NIGMS NIH HHS R01 GM046383
6 · The paper itself

Abstract

Xenopus oocytes and eggs provide a dramatic example of how the consequences of p42 mitogen-activated protein kinase (p42 MAPK) activation depend on the particular context in which the activation occurs. In oocytes, the activation of Mos, MEK, and p42 MAPK is required for progesterone-induced Cdc2 activation, and activated forms of any of these proteins can bring about Cdc2 activation in the absence of progesterone. However, in fertilized eggs, activation of the Mos/MEK/p42 MAPK pathway has the opposite effect, inhibiting Cdc2 activation and causing a G2 phase delay or arrest. In the present study, we have investigated the mechanism and physiological significance of the p42 MAPK-induced G2 phase arrest, using Xenopus egg extracts as a model system. We found that Wee1-depleted extracts were unable to arrest in G2 phase in response to Mos, and adding back Wee1 to the extracts restored their ability to arrest. This finding formally places Wee1 downstream of Mos/MEK/p42 MAPK. Purified recombinant p42 MAPK was found to phosphorylate recombinant Wee1 in vitro at sites that are phosphorylated in extracts. Phosphorylation by p42 MAPK resulted in a modest ( approximately 2-fold) increase in the kinase activity of Wee1 toward Cdc2. Titration experiments in extracts demonstrated that a twofold increase in Wee1 activity is sufficient to cause the delay in mitotic entry seen in Mos-treated extracts. Finally, we present evidence that the negative regulation of Cdc2 by Mos/MEK/p42 MAPK contributes to the presence of an unusually long G2 phase in the first mitotic cell cycle. Prematurely inactivating p42 MAPK in egg extracts resulted in a corresponding hastening of the first mitosis. The negative effect of p42 MAPK on Cdc2 activation may help ensure that the first mitotic cell cycle is long enough to allow karyogamy to be accomplished successfully.

Indexed as

Cell Cycle ProteinsNuclear ProteinsXenopus ProteinsAnimalsCDC2 Protein KinaseCell ExtractsEnzyme ActivationG2 PhaseInterphaseMitogen-Activated Protein Kinase 1MitosisOocytesPhosphorylationProtein KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesCDC2 Protein KinaseCell Cycle ProteinsCell ExtractsMitogen-Activated Protein Kinase 1MYT1 kinase, XenopusNuclear ProteinsProtein KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesTrypsinWEE1 protein, XenopusXenopus Proteins

Identifiers

PMID10712507
PMCPMC14818
OpenAlexW2163751122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.